Journal of Electrocardiology
Volume 42, Issue 2 , Pages 128-135 , March 2009

Influence of structural heart disease on characteristics of atrial fibrillation recurrence in patients with dual-chamber pacemakers

  • Michael J. Reiter, MD, PhD

      Affiliations

    • Department of Medicine, University of Colorado Health Sciences Center, Denver, CO, USA
    • Corresponding Author InformationCorresponding author. 5083 Oak Hollow Drive, Morrison, CO 80465, USA. Tel.: +1 303 697 6339.
    • ,
  • Manya Harsch, MS

      Affiliations

    • Vitatron Clinical Research, Minneapolis, MN, USA
    • ,
  • Te-Hsin Lung, PhD

      Affiliations

    • Vitatron Clinical Research, Minneapolis, MN, USA
    • ,
  • Dave Munneke, MS

      Affiliations

    • Vitatron Clinical Research, Minneapolis, MN, USA
    • ,
  • Michael H. Kim, MD, FACC

      Affiliations

    • Department of Medicine, Northwestern University, Feinberg School of Medicine Chicago, IL, USA
    • ,
  • Alaa Shalaby, MD, FACC

      Affiliations

    • Department of Medicine, VA Pittsburgh Healthcare System, Pittsburgh, PA, USA
    • ,
  • for the Vitatron AFm Registry Investigators

Received 26 November 2007

References 

  1. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: The Framingham Study. Stroke. 1991;22:983
  2. Kannel WB, Abbott RD, Savage DD, McNamara PM. Epidemiological features of chronic atrial fibrillation. The Framingham Study. N Engl J Med. 1982;306:1018
  3. Kerr CR, Boone J, Connolly SJ, et al. The Canadian Registry of Atrial Fibrillation: a noninterventional follow-up of patients after the first diagnosis of atrial fibrillation. Am J Cardiol. 1998;82:82N
  4. Page RL, Wilkinson WE, Clair WK, McCarthy EA, Pritchett ELC. Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia. Circulation. 1994;89:224
  5. Yamashita T, Murakawa Y, Sezaki K, et al. Circadian variation of paroxysmal atrial fibrillation. Circulation. 1997;96:1537
  6. Savelieva I, Camm AJ. Clinical relevance of silent atrial fibrillation: prevalence, prognosis, quality of life, and management. J Intervent Card Electrophysiol. 2000;4:369
  7. Israel CW, Olbrich HG, Hartung W, Wille B, Treusch S, Goethe JW. ncidence of atrial tachyarrhythmias in paced patients: first results of the BEATS study. Cardiostim. 2002;144/2:[Abst]
  8. Gregoratos G. ACC/AHA guidelines for implantation of cardiac pacemakers and antiarrhythmia devices. A report of the American College of Cardiology/American Heart Association task force on practice guidelines. J Amer Coll Cardiol. 1998;31:1175
  9. Fligner MA, Policello GE. Robust rank procedures for the Behrens-Fisher problem. J Am Stat Assoc. 1981;76:162
  10. Israel CW, Gronefeld G, Ehrlich JR, Li YG, Hohnloser SH. Long-term risk of recurrent atrial fibrillation as documented by implantable monitoring device: implications for optimal patient care. J Am Coll Cardiol. 2004;43:47
  11. Strickberger SA, Ip J, Saksena S, Curry K, Bahnson TD, Ziegler PD. Relationship between atrial tachyarrhythmias and symptoms. Heart Rhythm. 2005;2:125
  12. Israel CW, Grönefeld G, Ehrlich JR, Li YG, Hohnloser SH. Prevention of immediate reinitiation of atrial tachyarrhythmias by high-rate overdrive pacing: results from a prospective randomized trial. J Cardiovasc Electrophysiol. 2003;14:954
  13. Lee MA, Weachter R, Pollak S, Kremers MS, Naik A, Silverman R, et al. Can preventive and antitachycardia pacing reduce the frequency and burden of atrial tachyarrhythmias. The ATTEST Study Results. PACE. 2002;24II:541;[Abst]
  14. Gillis AM, Rose MS. Temporal patterns of paroxysmal atrial fibrillation following DDDR pacemaker implantation. Am J Cardiol. 2000;85:1445
  15. Gillis AM, Connolly SJ, Lacombe P, et al. Randomized crossover comparison of DDDR versus VDD pacing after atrioventricular junction ablation for prevention of atrial fibrillation. The Atrial Pacing Peri-ablation for Paroxysmal Atrial Fibrillation (PA3) study investigators. Circulation. 2000;102:736
  16. Pollak WM, Simmons JD, Interian A, et al. Clinical utility of intratrial pacemaker stored electrograms to diagnose atrial fibrillation and flutter. Pacing Clin Electrophysiol. 2001;24:424
  17. Saksena S, Hettrick DA, Koehller JL, Grammatico A, Padeletti L. Progression of paroxysmal atrial fibrillation to persistent atrial fibrillation in patients with bradyarrhythmias. Am Heart J. 2007;154:801
  18. Hettrick DA, Adler S, Padeletti L, Koehler J, Saksena S. Progression of atrial tachyarrhythmia burden over time in atrial fibrillation patients with or without cardiovascular disease. Heart Rhythm. 2004;1:S272;[Abst]
  19. Gillis AM, Wyse G, Connolly SJ, et al. for the Atrial Pacing Periablation for Paroxysmal Atrial Fibrillation (PA3) Study Investigators. Atrial pacing periablation for prevention of paroxysmal atrial fibrillation. Circulation. 1999;99:2553
  20. Gillis AM, Morck M. Atrial fibrillation after DDDR pacemaker implantation. J Cardiovasc Electrophysiol. 2002;13:542
  21. Gilliam FR, Guinn VL, Nsah E, Gaucher JP, McGuire MT, Hopper DL. The prevalence of atrial fibrillation in sick sinus syndrome patients with pacemakers and no history of atrial arrhythmias. PACE. 2003;26:II–1050[Abst]
  22. Stroke Prevention in Atrial Fibrillation Investigators. Stroke Prevention in Atrial Fibrillation Study: final results. Circulation. 1991;84:527
  23. The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. N Engl J Med. 1990;323:1505
  24. MOST Investigators , Glotzer TV, Helkamp AS, et al. Atrial high rate episodes detected by pacemaker diagnostics predict death and stroke: Report of the atrial diagnostics ancillary study of the Mode Selection Trial (MOST). Circulation. 2003;107:1614
  25. Capucci A, Santini M, Padeletti L, et al. on behalf of the Italian AT500 Registry Investigators Monitored atrial fibrillation duration predicts arterial embolic events in patients suffering from bradycardia and atrial fibrillation implanted with antitachycardia pacemakers. J Am Coll Cardiol. 2005;46:1913
  26. Israel CW, Hügl B, Unterberg C, et al. on behalf of the AT500 Verification Study Investigators: pace-termination and pacing prevention of atrial tachyarrhythmias: results from a multicenter study with an implantable device for atrial therapy. J Cardiovasc Electrophysiol. 2001;12:1121
  27. Fitts SM, Hill MR, Mehra R, Gillis AM. High rate atrial tachyarrhythmia detections in implantable pulse generators: low incidence of false-positive detections. PACE. 2000;23:1080
  28. Carlioz . Accuracy of atrial tachyarrhythmia monitoring in the Selection device: correlation with an external Holter recording. Europace. 2001;419;[Abst]

☆ This study was supported by Vitatron Clinical Research, Minneapolis, MN. Manya Harsch, Te-Hsin Lung, and Dave Munneke are employees of Medtronic (Minneapolis, MN, USA).

PII: S0022-0736(08)00353-1

doi: 10.1016/j.jelectrocard.2008.09.002

Journal of Electrocardiology
Volume 42, Issue 2 , Pages 128-135 , March 2009

Article Tools

* Image Usage & Resolution